Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection

The present invention relates to pharmaceutical compositions useful in the treatment of heart transplant rejection in mammals which comprise a pharmaceutically acceptable excipient, a therapeutically effective amount of a non-peptide CCR1 receptor antagonist and a sub-nephrotoxic amount of cyclospor...